Hepatitis E virus (HEV) infection can lead to acute and chronic hepatitis as well as to
extrahepatic manifestations such as neurological and renal disease; it is the most common …

Hepatitis E virus (HEV) infection is a worldwide disease. An improved understanding of the
natural history of HEV infection has been achieved within the last decade. Several reservoirs …

Hepatitis E may be the most common cause of acute hepatitis in the world, occurring
primarily in developing countries but increasingly recognized in developed countries. It can …

Hepatitis E virus (HEV) was discovered during the Soviet occupation of Afghanistan in the
1980s, after an outbreak of unexplained hepatitis at a military camp. A pooled faecal extract …

The fast and untraceable virus mutations take lives of thousands of people before the
immune system can produce the inhibitory antibody. The recent outbreak of COVID-19 …

The 2019 coronavirus pandemic remains a major public health concern. Neutralizing
antibodies (nAbs) represent a cutting-edge antiviral strategy. We focus here on severe acute …

Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis throughout the
world. Most infections are acute but they can become chronic in immunocompromised …

Metabolomics is a powerful new technology that allows for the assessment of global
metabolic profiles in easily accessible biofluids and biomarker discovery in order to …

Human vaccines against three viruses use recombinant virus-like particles (VLPs) as the
antigen: hepatitis B virus, human papillomavirus, and hepatitis E virus. VLPs are excellent …

Although most hepatitis E virus (HEV) infections are asymptomatic, some can be severe,
causing fulminant hepatitis and extra-hepatic manifestations, including neurological and …